News and Events => Science & Medical News => Topic started by: Jessica_Rose on May 07, 2026, 03:22:44 PM Return to Full Version
Title: Major British medical group reverses course & embraces controversial guidance...
Post by: Jessica_Rose on May 07, 2026, 03:22:44 PM
Post by: Jessica_Rose on May 07, 2026, 03:22:44 PM
Major British medical group reverses course & embraces controversial guidance on trans health care
https://www.lgbtqnation.com/2026/05/major-british-medical-group-reverses-course-embraces-controversial-guidance-on-trans-health-care/
Faefyx Collington (7 May 2026)
The British Medical Association (BMA) – the trade union for doctors and medical students in the United Kingdom – has voiced its support for the controversial Cass Review of gender-affirming care, formally dropping its previous opposition to the review and to Cass' recommendations.
"[Dr. Hilary Cass] has been vindicated in the way she approached the data," the lead of BMA's review and chair of its board of science, Professor David Strain, told The Times. Strain claimed that Cass "approached an area of significant uncertainty with that prime rule of medicine, of 'first, do no harm.'" When asked if he could name a single recommendation from the review that he opposed, he responded, "I can't."
The Cass Review, first published in April 2024, enraged trans advocates by pushing for treatment of trans youth to move away from medical intervention in favor of a more "holistic" approach. Cass recommended therapy, suggesting the need for treatment of coexisting mental illness, as well as examining potential neurodivergence or family issues.
The medical form of gender-affirming care that Cass recommends moving away from is supported by all major U.S. medical associations. That treatment – which has been deemed safe and, in many cases, reversible – has been linked to reduced rates of depression, anxiety, and suicide attempts in trans youth.
https://www.lgbtqnation.com/2026/05/major-british-medical-group-reverses-course-embraces-controversial-guidance-on-trans-health-care/
Faefyx Collington (7 May 2026)
The British Medical Association (BMA) – the trade union for doctors and medical students in the United Kingdom – has voiced its support for the controversial Cass Review of gender-affirming care, formally dropping its previous opposition to the review and to Cass' recommendations.
"[Dr. Hilary Cass] has been vindicated in the way she approached the data," the lead of BMA's review and chair of its board of science, Professor David Strain, told The Times. Strain claimed that Cass "approached an area of significant uncertainty with that prime rule of medicine, of 'first, do no harm.'" When asked if he could name a single recommendation from the review that he opposed, he responded, "I can't."
The Cass Review, first published in April 2024, enraged trans advocates by pushing for treatment of trans youth to move away from medical intervention in favor of a more "holistic" approach. Cass recommended therapy, suggesting the need for treatment of coexisting mental illness, as well as examining potential neurodivergence or family issues.
The medical form of gender-affirming care that Cass recommends moving away from is supported by all major U.S. medical associations. That treatment – which has been deemed safe and, in many cases, reversible – has been linked to reduced rates of depression, anxiety, and suicide attempts in trans youth.